Sort
51,570 grants matching “autoimmune disease”
UVEITIS GENE-EXPRESSION PROFILING
$495,553James T Rosenbaum · Oregon Health & Science University · R01 · FY2007 · EY
Skin Homing T Cells
$495,538Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2013 · AR
Role of Transcription Coactivator OCA-B in Gene Poising and Immunological Memory
$495,529Dean Tantin · University Of Utah · R01 · FY2020 · AI
Messenger RNA Turnover in Mammalian Cells
$495,528Ann-Bin Shyu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2010 · GM
Multimodal analysis of the "honeymoon period" in autoimmune diabetes
$495,495Howard W Davidson · University Of Colorado Denver · R01 · FY2024 · DK
Role of Innate and Adaptive Immune Systems in Drug-Induced Liver Disease
$495,446Lance R Pohl · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Cell Sorting and Analysis Core
$495,364Richard M Locksley · University Of California, San Francisco · P01 · FY2008 · AI
Engineering Functional Salivary Glands Using Micropatterned Scaffolds
$495,345Melinda Larsen · State University Of New York At Albany · R01 · FY2012 · DE
Molecular and Structural Basis for T Cell Costimulation
$495,315Stanley G Nathenson · Albert Einstein College Of Medicine · R01 · FY2008 · AI
Assembly and Trafficking of MHC Class II Molecules
$495,308Hidde L Ploegh · Whitehead Institute For Biomedical Res · R01 · FY2008 · AI
MicroRNA directed pathway discovery in allergy and asthma
$495,259Karl Mark Ansel · University Of California, San Francisco · R01 · FY2025 · HL
Role of ROR??t in the transcriptional regulatory network underlying Th17 lineage
$495,241Dan R Littman · New York University School Of Medicine · RC1 · FY2010 · AI
Career Development and Outreach in Musculoskeletal, Autoimmune and Skin Disease
$495,202Mario Cerritelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR
Interdisciplinary Immunology Training Program
$495,189David G. Schatz · Yale University · T32 · FY2021 · AI
Gain-of-function complement activators as a new class of immunotherapeutic molecules
$495,105Ruben Martinez Barricarte · Vanderbilt University Medical Center · R01 · FY2023 · CA
Gain-of-function complement activators as a new class of immunotherapeutic molecules
$495,105Ruben Martinez Barricarte · Vanderbilt University Medical Center · R01 · FY2025 · CA
Developing novel immunoassays specific for thyroid stimulating and TSHblocking autoantibodies
$495,097Ling Tian · Mediomics, Llc · R44 · FY2021 · DK
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
$495,000Robert P Schleimer · Northwestern University At Chicago · P01 · FY2021 · AI
Investigating the Mechanism Regulating Alternative Splicing of Neural Agin: A Novel Therapeutic Entry Point for Congenital Myasthenic Syndrome
$495,000Matteo Ruggiu · St. John'S University · R15 · FY2016 · GM
IN VIVO TREATMENT OF EAE WITH ANTI I-A ANTIBODIES
$494,981Stanford University · R01 · FY2001 · NS
Hormones/Genes in Women's Health: From Bench to Bedside
$494,940Jill M Goldstein · Brigham And Women'S Hospital · K12 · FY2007 · HD
Rip Proteins in Innate Immune Signaling
$494,935Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
$494,929Ann Marshak-Rothstein · Univ Of Massachusetts Med Sch Worcester · R37 · FY2023 · AI
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
$494,929Ann Marshak-Rothstein · Univ Of Massachusetts Med Sch Worcester · R37 · FY2022 · AI
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
$494,929Ann Marshak-Rothstein · Univ Of Massachusetts Med Sch Worcester · R37 · FY2021 · AI